APA (7th ed.) Citation

PALMA, G., CACCIOPPOLI, C., DORIA, R., ANNAMARIA GENCHI, V., CALDERONI, I., BRAUN, A., . . . PERRINI, S. (2023). 246-OR: Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter. Diabetes (New York, N.Y.), 72(Supplement_1), 1. https://doi.org/10.2337/db23-246-OR

Chicago Style (17th ed.) Citation

PALMA, GIUSEPPE, et al. "246-OR: Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter." Diabetes (New York, N.Y.) 72, no. Supplement_1 (2023): 1. https://doi.org/10.2337/db23-246-OR.

MLA (9th ed.) Citation

PALMA, GIUSEPPE, et al. "246-OR: Dapagliflozin Counteracts the Proapoptotic Effects of the Secretome of Visceral Adipose Cells from Obese Subjects in Human Cardiac Progenitor Cells via the SGLT2 Cotransporter." Diabetes (New York, N.Y.), vol. 72, no. Supplement_1, 2023, p. 1, https://doi.org/10.2337/db23-246-OR.